SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-15-005588
Filing Date
2015-07-31
Accepted
2015-07-31 17:08:52
Documents
4
Period of Report
2015-07-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k072915_soligenix.htm 8-K 24637
2 EQUITY PURCHASE AGREEMENT f8k072915ex10i_soligenix.htm EX-10.1 159588
3 REGISTRATION RIGHTS AGREEMENT f8k072915ex10ii_soligenix.htm EX-10.2 66957
4 CONVERTIBLE PROMISSORY NOTE f8k072915ex10iii_soligenix.htm EX-10.3 20677
  Complete submission text file 0001213900-15-005588.txt   273320
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 151020059
SIC: 2834 Pharmaceutical Preparations